METHOD AND ASSAY FOR DETERMINING FAS EXPRESSION

Number of patents in Portfolio can not be more than 2000

United States of America Patent

APP PUB NO 20140127714A1
SERIAL NO

14150007

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

Methods and immunoassays for the determination of fatty acid synthase (FAS) expression in patients having or suspected of having a proliferative disorder, especially prostate cancer, are disclosed. The sensitive method and assay detect the level of expression of FAS in a biological sample using antibodies that are highly specific for FAS. The method and assay can be used to monitor the progression of cancer, and/or to predict the efficacy of certain treatments or the likelihood of recurrence of the cancer.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
NUCLEA BIOTECHNOLOGIES INC105 SOUTH STREET PITTSFIELD MA 01201

International Classification(s)

  • [Classification Symbol]
  • [Patents Count]

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Muraca, Patrick J Pittsfield, US 48 438

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation